يعرض 1 - 10 نتائج من 122 نتيجة بحث عن '"Alison M. Lawrie"', وقت الاستعلام: 1.56s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8

    المساهمون: University of Oxford, National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH), National Institutes of Health [Bethesda] (NIH), Biologie de Plasmodium et Vaccins - Malaria Parasite Biology and Vaccines, Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), London School of Hygiene and Tropical Medicine (LSHTM), International Centre for Genetic Engineering and Biotechnology [New Delhi] (ICGEB), The VAC069 and VAC071 trials were funded by the European Union’s Horizon 2020 research andinnovation program under grant agreement 733073 for MultiViVax. The VAC079 trial was funded bythe Wellcome Trust Malaria Infection Study in Thailand (MIST) program [212336/Z/18/Z]. For thepurpose of open access, the author has applied a CC BY public copyright licence to any AuthorAccepted Manuscript version arising from this submission. This work was also supported in part byhe UK Medical Research Council (MRC) [G1100086] and the National Institute for Health Research(NIHR) Oxford Biomedical Research Centre (BRC). DJML holds a NIHR Academic ClinicalFellowship. The views expressed are those of the authors and not necessarily those of the NHS, theNIHR or the Department of Health. The GIA work was supported by the Intramural Program of theNational Institutes of Health, National Institute of Allergy and Infectious Diseases. RWM and FMwere supported by the UK MRC (Career Development Award MR/M021157/1). Development ofPvDBPII as a vaccine candidate was supported by grants from the Biotechnology Industry ResearchAssistance Council (BIRAC), New Delhi and PATH Malaria Vaccine Initiative. MVDP wassupported by grants from the Bill and Melinda Gates Foundation and Department of Biotechnology(DBT), Government of India. This work was also supported in part by grants from Agence Nationalede Recherche to CEC (ANR-18- CE15-0026 and ANR 21 CE15-0013-01). CEC is supported by theFrench Government's Laboratoire d'Excellence 'PARAFRAP' (ANR-11-LABX-0024-PARAFRAP).FJM was supported by a Fellowship from Ecole Doctorale BioSPC, Université Paris Cité. CMN helda Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship [209200/Z/17/Z]. TAR held aWellcome Trust Research Training Fellowship [108734/Z/15/Z]. SB and SJD are Jenner Investigatorsand SJD held a Wellcome Trust Senior Fellowship [106917/Z/15/Z]., ANR-18-CE15-0026,VIPeRs,Voies d'invasion des réticulocytes humains par Plasmodium vivax(2018), ANR-21-CE15-0013,PvINV,Analyse de la structure-fonction des ligands du stade sanguin de Plasmodium vivax pour l'invasion(2021), ANR-11-LABX-0024,ParaFrap,Alliance française contre les maladies parasitaires(2011), European Project: 733073,H2020-SC1-2016-RTD,MultiVivax(2017)

  9. 9
  10. 10